Author: Jordan Smith

The “Cholangiocarcinoma: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031” report features an extensive study on the marketed, clinical and preclinical molecules available / being developed for the treatment of... Read More

Over the years, a number of companies have developed several novel and advanced drug delivery devices, which are reported to be capable of addressing the known challenges in this domain.... Read More

Growing research activity in the RAS targeting domain has resulted in a surge in the interest of biopharmaceutical developers in this rapidly evolving sector. These therapies are being developed against... Read More

Post the onset of COVID-19 pandemic, there has been a decline in number of patients visiting laboratories for sample collection and testing. Owing to the risk of infection associated with... Read More

This report provides an in-depth analysis of the product pipeline and developer companies, highlighting the current treatment practices, emerging drugs, and market share of the individual therapies. In addition to... Read More

Over the years, advances in drug / therapy development processes have led the pharmaceutical industry to gradually shift from a one-drug treats all model to a more personalized approach of... Read More

Over the past few decades, biopharmaceuticals have gained significant popularity owing to their therapeutic efficacy, favorable safety profiles and ability to treat a wide variety of disease indications, which are... Read More

The “Chronic Myelomonocytic Leukemia (CMML): Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031” report features an extensive study on the marketed, clinical and preclinical molecules available / being developed for... Read More

The “Anaplastic Astrocytoma: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031” report features an extensive study on the marketed, clinical and preclinical molecules available / being developed for the treatment... Read More

Although biopharmaceuticals offer significant profit margins and have been proven to be effective in treating a myriad of diseases, they are generally associated with high costs of development and complex... Read More